Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

The global vaccine CDMO market is set to witness a growth rate of 8% in the next 5 years. Increasing demand for vaccines, ...

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...

Wacker Biotech announced a strategic collaboration with RNAV8 Bio, a pioneer in mRNA engineering for the development of ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

South Korean researchers have, for the first time in the world, uncovered how messenger ribonucleic acid (mRNA) vaccines ...